Tumor-initiating cells of HER2-positive carcinoma cell lines express the highest oncoprotein levels and are sensitive to trastuzumab.

MLA

Magnifico, Alessandra, et al. “Tumor-Initiating Cells of HER2-Positive Carcinoma Cell Lines Express the Highest Oncoprotein Levels and Are Sensitive to Trastuzumab.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, vol. 15, no. 6, Mar. 2009, pp. 2010–21. EBSCOhost, https://doi.org/10.1158/1078-0432.CCR-08-1327.

APA

Magnifico, A., Albano, L., Campaner, S., Delia, D., Castiglioni, F., Gasparini, P., Sozzi, G., Fontanella, E., Menard, S., & Tagliabue, E. (2009). Tumor-initiating cells of HER2-positive carcinoma cell lines express the highest oncoprotein levels and are sensitive to trastuzumab. Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 15(6), 2010–2021. https://doi.org/10.1158/1078-0432.CCR-08-1327

Chicago

Magnifico, Alessandra, Luisa Albano, Stefano Campaner, Domenico Delia, Fabio Castiglioni, Patrizia Gasparini, Gabriella Sozzi, Enrico Fontanella, Sylvie Menard, and Elda Tagliabue. 2009. “Tumor-Initiating Cells of HER2-Positive Carcinoma Cell Lines Express the Highest Oncoprotein Levels and Are Sensitive to Trastuzumab.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 15 (6): 2010–21. doi:10.1158/1078-0432.CCR-08-1327.